Provided by Tiger Trade Technology Pte. Ltd.

Ocular Therapeutix

11.27
-0.0100-0.09%
Post-market: 11.270.00000.00%19:59 EST
Volume:6.65M
Turnover:76.06M
Market Cap:2.40B
PE:-7.83
High:11.94
Open:11.18
Low:10.77
Close:11.28
52wk High:16.44
52wk Low:5.79
Shares:213.05M
Float Shares:183.00M
Volume Ratio:0.71
T/O Rate:3.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4387
EPS(LYR):-1.2227
ROE:-81.83%
ROA:-36.61%
PB:9.30
PE(LYR):-9.22

Loading ...

Ocular Therapeutix rises 11.7%

TIPRANKS
·
Jan 15

BUZZ-Ocular shares surge after report Sanofi revives acquisition interest

Reuters
·
Jan 15

Ocular Therapeutix Shares Rise 11.1%

THOMSON REUTERS
·
Jan 15

Ocular Therapeutix on Pace for Longest Losing Streak Since April 2024 -- Data Talk

Dow Jones
·
Jan 06

Ocular Therapeutix (OCUL) Is Down 10.9% After Pivoting AXPAXLI To Single-Trial NDA Pathway – Has The Bull Case Changed?

Simply Wall St.
·
Dec 19, 2025

RBC Capital Adjusts Ocular Therapeutix Price Target to $24 From $17, Maintains Outperform Rating

MT Newswires Live
·
Dec 16, 2025

Ocular Therapeutix Is Maintained at Buy by Chardan Capital

Dow Jones
·
Dec 09, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Five Below, Boeing, Instacart

Reuters
·
Dec 09, 2025

Ocular Therapeutix Stock Skyrockets On Faster FDA Path For Vision Drug

Benzinga_recent_news
·
Dec 09, 2025

Paramount Skydance, Wave Life Sciences, Ocular Therapeutix, Carvana And Other Big Stocks Moving Higher On Monday

Benzinga_recent_news
·
Dec 09, 2025

Ocular Therapeutix Up Over 27%, on Track for Highest Close Since May 2021 -- Data Talk

Dow Jones
·
Dec 09, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Micron, NextEra Energy, Ocular Therapeutix

Reuters
·
Dec 08, 2025

Ocular Therapeutix Shares Rise 25.1% on Plans to Fast-Track FDA Filing for Eye Disease Drug

THOMSON REUTERS
·
Dec 08, 2025

Ocular Therapeutix Inc : RBC Raises Target Price to $30 From $24

THOMSON REUTERS
·
Dec 08, 2025

Ocular Therapeutix Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Dec 08, 2025

BRIEF-Ocular Therapeutix Says SOL-1 Topline Data Expected In First Quarter 2026

Reuters
·
Dec 08, 2025

BUZZ-Ocular Therapeutix rises on plans to fast-track FDA filing for eye disease drug

Reuters
·
Dec 08, 2025

Ocular Therapeutix™ Announces Plans to Accelerate Nda Submission Timeline for Axpaxli™ in Wet Amd

THOMSON REUTERS
·
Dec 08, 2025

Ocular Therapeutix Inc - Sol-1 Topline Data Expected in First Quarter 2026

THOMSON REUTERS
·
Dec 08, 2025

AXPAXLI NDA Acceleration Might Change The Case For Investing In Ocular Therapeutix (OCUL)

Simply Wall St.
·
Dec 08, 2025